Frontiers in Oncology | Breast Cancer

Case Report

Published on 13 Aug 2025

Case Report: Unlocking opportunities in HER2-targeted antibody-drug conjugates for bulky leptomeningeal metastatic breast cancer

in Breast Cancer

Alessandro Leal
Douglas Kondziolka
Donato Pacione
Stacy Antwi
Sylvia Kurz
Nancy Lin
Sylvia Adams

Frontiers in Oncology

doi 10.3389/fonc.2025.1559085

2,260 views

Original Research

Published on 13 Aug 2025

Multidimensional evaluation of 3.0T HR-MRI, ultrasound imaging, and GATA3 protein expression in breast cancer, and their prognostic analysis

in Breast Cancer

Yang Bai
Ting Xie
Xiangyang Mo
Yong Luo
Man Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1587243

1,174 views

Case Report

Published on 12 Aug 2025

Case Report: Breast ductal carcinoma in situ with microinvasion: a case tracked over 13 years

in Breast Cancer

Sibei Ruan
Jian Zhou
Rui Tang
Tao Wang
Xia Gao
Lixian Mou
Mingxi Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1560366

2,942 views

Original Research

Published on 12 Aug 2025

Analysis of dynamic contrast-enhanced T1-weighted imaging parameters in type II TIC breast lesions

in Breast Cancer

Jimei Jiang
Weibin Ma
Ming Li
Shanhua Han
Yu Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1403262

1,423 views

Systematic Review

Published on 07 Aug 2025

The efficacy and immune-mediated safety of PD-1/PD-L1 combined with neoadjuvant chemotherapy in triple-negative breast cancer: a meta-analysis

in Breast Cancer

Xiao Yan
Qi Lv
Jiangzhuo Wu
Jiang Fang
Lin Peng
Xiaobo Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1635418

5,886 views

Original Research

Published on 06 Aug 2025

Clinical study of 99mTc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer

in Breast Cancer

Minxue Zhuang
Yidan Lin
HongBin Qiu
Wei Chen
Ruo Wang
HuanHong Zeng
Mengbo Lin
Hui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1568550

1,668 views

Original Research

Published on 06 Aug 2025

Analysis of methylation features associated with neoadjuvant efficacy in HER2-positive breast cancer

in Breast Cancer

Zibai Guo
Jinhong Wei
Anping Gui
Xuanhua Liang
Pengli Yu
Jing Bai
Liang Cui
Xuefeng Xia
Shihui Ma

Frontiers in Oncology

doi 10.3389/fonc.2025.1610093

1,877 views

Original Research

Published on 05 Aug 2025

SPOCK1 promotes the progression of breast cancer by modulating cancer-associated fibroblasts and exerts a synergistic effect with ANXA2

in Breast Cancer

Yuan Jie
Xin Fei
Meng Fan

Frontiers in Oncology

doi 10.3389/fonc.2025.1619171

3,161 views
2 citations

Review

Published on 04 Aug 2025

Liquid biopsy in TNBC: significance in diagnostics, prediction, and treatment monitoring

in Breast Cancer

Jiayi Sheng
Xiaolong Zong

Frontiers in Oncology

doi 10.3389/fonc.2025.1607960

3,890 views
3 citations

Original Research

Published on 04 Aug 2025

Effects of immersive virtual therapy on psychological and physical wellbeing in women with breast cancer at different stages of disease and treatment conditions: an experimental comparative study

in Breast Cancer

Oliver Czech
Rafal Matkowski
Jakub Skórniak
Iwona Malicka

Frontiers in Oncology

doi 10.3389/fonc.2025.1581604

2,899 views

Correction

Published on 01 Aug 2025

Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial

in Breast Cancer

Vinod K. Ramani
Ajaikumar Basavalinga Sadashivaiah
Radheshyam Naik

Frontiers in Oncology

doi 10.3389/fonc.2025.1658958

1,151 views

Original Research

Published on 01 Aug 2025

Efficacy and safety of biosimilar trastuzumab (HLX02) in patients with HER2-positive advanced breast cancer: a retrospective real-world analysis

in Breast Cancer

Xuan Ye
Linlin Wang
Wensheng Liu
Mengmeng Wang
Zihan Guo
Han Shan
Qing Zhai
Qiong Du

Frontiers in Oncology

doi 10.3389/fonc.2025.1622854

2,682 views
1 citation

Opinion

Published on 31 Jul 2025

Redefining “normal”: discovery of aneuploid epithelial cells in healthy breast tissue

in Breast Cancer

Xiaoyan Chen
Xiaoling Liu
Jiapeng Xue
Zhi Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1558977

1,120 views

Case Report

Published on 30 Jul 2025

Case Report: Personalized treatment in stage IV breast cancer using the patient-derived organoids

in Breast Cancer

Wu Ying
Hao Pi
Xiaowu He
Yuan Sheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1629690

2,327 views
4 citations

Original Research

Published on 30 Jul 2025

Using baseline MRI radiomics to predict the tumor shrinkage patterns in HR-Positive, HER2-Negative Breast Cancer

in Breast Cancer

Lijia Wang
Yongchen Wang
Li Yang
Jialiang Ren
Qian Xu
Yingmin Zhai
Tao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1539644

1,964 views

Original Research

Published on 30 Jul 2025

Exploration of the clinical prognostic model of BRCA based on PCAT7

in Breast Cancer

Zhi Zhang
Chaocheng Xiang
Tong Chen
Aimin Ma
Xu Wang
Jiaying Li
Yixuan Chen
Chengyu Huang
Ting Li
Danmei Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1580858

1,640 views

Original Research

Published on 29 Jul 2025

SHCBP1 drives tumor progression in triple-negative breast cancer

in Breast Cancer

Huiling Wang
Huijuan Dai
Liheng Zhou
Yanping Lin
Wenjin Yin
Jingsong Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1587236

2,462 views

Case Report

Published on 28 Jul 2025

Case Report: Breast cancer in pregnancy with placental metastasis

in Breast Cancer

Yongming Lin
Xinru Xie
Jiayi Wang
Hongbing Chen
Ningning Wan
Jianqing Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1573915

1,947 views

Original Research

Published on 24 Jul 2025

Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial

in Breast Cancer

Mark Hensley
Justin Lengfeld
Steven Stoesz
Michelle Edwards
Franklin Pass
Gillian L. Hirst
Lamorna Brown-Swigart
Laura van ‘t Veer
Laura J. Esserman
Heather Beckwith

Frontiers in Oncology

doi 10.3389/fonc.2025.1605120

1,975 views

Original Research

Published on 23 Jul 2025

Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients

in Breast Cancer

Xiaoyan Fu
Ze Huang
Zongyan Li
Zuxiao Chen
Zhijie Wu
Qingyu Yang
Haiyan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1546044

2,120 views
1 citation

Review

Published on 23 Jul 2025

Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancer

in Breast Cancer

Vishnu Prasath
Briana To
Dionisia M. Quiroga
Bridget A. Oppong
Kai Johnson
Benjin Facer
Robert Wesolowski

Frontiers in Oncology

doi 10.3389/fonc.2025.1465147

2,529 views

Original Research

Published on 21 Jul 2025

JMJD8 overexpression in breast cancer: implications for diagnosis, prognosis, and immune microenvironment interactions

in Breast Cancer

Chenlei Zhu
Tianyi Xi
Guorong Yang
Wen Lu
Sentai Wang
Jiwei Cao

Frontiers in Oncology

doi 10.3389/fonc.2025.1536278

2,081 views

Case Report

Published on 18 Jul 2025

Case Report: A successful multidisciplinary approach to doxorubicin extravasation from a PICC-port in a patient with breast cancer

in Breast Cancer

Concetta Calabrò
Serena Iacovelli
Giuseppe De Palma
Giuseppe Carravetta
Domenica Garofalo
Francesco Giotta
Agnese Latorre
Patrizia Nardulli
Cosmo Maurizio Ressa
Elsa Vitale

Frontiers in Oncology

doi 10.3389/fonc.2025.1534112

2,812 views
2 citations

Original Research

Published on 17 Jul 2025

Integrating single-cell regulatory atlas and multi-omics data for differential treatment response and multimodal predictive modeling in CDK 4/6 inhibitor-treated breast cancer

in Breast Cancer

Li Yan
Sijie Chen
Ran Ran
Shidi Zhao
Jing Huang
Jin Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1585574

3,362 views
1 citation

1,693 articles

articles

Case Report: Unlocking opportunities in HER2-targeted antibody-drug conjugates for bulky leptomeningeal metastatic breast cancer

Multidimensional evaluation of 3.0T HR-MRI, ultrasound imaging, and GATA3 protein expression in breast cancer, and their prognostic analysis

Case Report: Breast ductal carcinoma in situ with microinvasion: a case tracked over 13 years

Analysis of dynamic contrast-enhanced T1-weighted imaging parameters in type II TIC breast lesions

The efficacy and immune-mediated safety of PD-1/PD-L1 combined with neoadjuvant chemotherapy in triple-negative breast cancer: a meta-analysis

Clinical study of 99mTc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer

Analysis of methylation features associated with neoadjuvant efficacy in HER2-positive breast cancer

SPOCK1 promotes the progression of breast cancer by modulating cancer-associated fibroblasts and exerts a synergistic effect with ANXA2

Liquid biopsy in TNBC: significance in diagnostics, prediction, and treatment monitoring

Effects of immersive virtual therapy on psychological and physical wellbeing in women with breast cancer at different stages of disease and treatment conditions: an experimental comparative study

Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial

Efficacy and safety of biosimilar trastuzumab (HLX02) in patients with HER2-positive advanced breast cancer: a retrospective real-world analysis

Redefining “normal”: discovery of aneuploid epithelial cells in healthy breast tissue

Case Report: Personalized treatment in stage IV breast cancer using the patient-derived organoids

Using baseline MRI radiomics to predict the tumor shrinkage patterns in HR-Positive, HER2-Negative Breast Cancer

Exploration of the clinical prognostic model of BRCA based on PCAT7

SHCBP1 drives tumor progression in triple-negative breast cancer

Case Report: Breast cancer in pregnancy with placental metastasis

Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial

Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients

Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancer

JMJD8 overexpression in breast cancer: implications for diagnosis, prognosis, and immune microenvironment interactions

Case Report: A successful multidisciplinary approach to doxorubicin extravasation from a PICC-port in a patient with breast cancer

Integrating single-cell regulatory atlas and multi-omics data for differential treatment response and multimodal predictive modeling in CDK 4/6 inhibitor-treated breast cancer